Joseph Zarzewsky
Director/Board Member at COLLPLANT BIOTECHNOLOGIES LTD.
Net worth: - $ as of 30/03/2024
Profile
Joseph Zarzewsky is currently a Director at Wize Pharma Ltd., an Independent Director at Brimag Digital Age Ltd.
and CollPlant Biotechnologies Ltd., and Vice President of Business Development at Mitrelli Group Ltd.
He previously served as a Director at Wize Pharma, Inc. from 2017 to 2021.
He also held Vice President positions in marketing at Clal Insurance Enterprises Holdings Ltd.
and The Israel Postal Co. Ltd.
Mr. Zarzewsky holds graduate degrees from the University of California, Berkeley, Tel-Aviv University, and the College of Law & Business.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
19/03/2024 | 0 ( -.--% ) | - $ | 30/03/2024 |
Joseph Zarzewsky active positions
Companies | Position | Start |
---|---|---|
COLLPLANT BIOTECHNOLOGIES LTD. | Director/Board Member | 31/07/2019 |
BRIMAG DIGITAL AGE LTD. | Director/Board Member | 09/01/2019 |
Mitrelli Group Ltd
Mitrelli Group Ltd Miscellaneous Commercial ServicesCommercial Services Mitrelli Group Ltd. operates as a commercial enterprise services. It offers education and professional training, health, agriculture, telecom and information technology, water, energy, fishery and mineral, and housing and construction technologies. The company is headquartered in Larnaca, Cyprus. | Corporate Officer/Principal | 31/05/2010 |
Wize Pharma Ltd.
Wize Pharma Ltd. Electronic ComponentsElectronic Technology Wize Pharma Ltd. engages in purchase, marketing, sale, and distribution of drug for treatment of dry eye and other ophthalmologic diseases. The company was founded on June 23, 1982 and is headquartered in Hod HaSharon, Israel. | Director/Board Member | 03/04/2018 |
Former positions of Joseph Zarzewsky
Companies | Position | End |
---|---|---|
MAWSON INFRASTRUCTURE GROUP INC. | Director/Board Member | 08/03/2021 |
The Israel Postal Co. Ltd.
The Israel Postal Co. Ltd. General GovernmentGovernment The Israel Postal Co. Ltd. is engaged in providing to the population of the State of Israel postal services, the Postal Bank and a range of advanced services. The company was founded in 2003 and is headquartered in Jerusalem, Israel. | Sales & Marketing | - |
CLAL INSURANCE ENTERPRISES HOLDINGS LTD. | Sales & Marketing | - |
Training of Joseph Zarzewsky
University of California, Berkeley | Graduate Degree |
Tel-Aviv University | Graduate Degree |
College of Law & Business | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
CLAL INSURANCE ENTERPRISES HOLDINGS LTD. | Finance |
BRIMAG DIGITAL AGE LTD. | Retail Trade |
COLLPLANT BIOTECHNOLOGIES LTD. | Health Technology |
Private companies | 4 |
---|---|
Wize Pharma Ltd.
Wize Pharma Ltd. Electronic ComponentsElectronic Technology Wize Pharma Ltd. engages in purchase, marketing, sale, and distribution of drug for treatment of dry eye and other ophthalmologic diseases. The company was founded on June 23, 1982 and is headquartered in Hod HaSharon, Israel. | Electronic Technology |
The Israel Postal Co. Ltd.
The Israel Postal Co. Ltd. General GovernmentGovernment The Israel Postal Co. Ltd. is engaged in providing to the population of the State of Israel postal services, the Postal Bank and a range of advanced services. The company was founded in 2003 and is headquartered in Jerusalem, Israel. | Government |
Mitrelli Group Ltd
Mitrelli Group Ltd Miscellaneous Commercial ServicesCommercial Services Mitrelli Group Ltd. operates as a commercial enterprise services. It offers education and professional training, health, agriculture, telecom and information technology, water, energy, fishery and mineral, and housing and construction technologies. The company is headquartered in Larnaca, Cyprus. | Commercial Services |
Wize Pharma, Inc.
Wize Pharma, Inc. Pharmaceuticals: MajorHealth Technology Wize Pharma, Inc. develops, produces and sells electronic and electro-optical systems. It focuses on treatment of ophthalmic disorders including Dry Eye Syndrome and other inflammatory conditions. The company holds rights to purchase, market, sell, and distribute LO2A. The company was founded on December 10, 1999 and is headquartered in Hod Ha'Sharon, Israel. | Health Technology |
- Stock Market
- Insiders
- Joseph Zarzewsky